Provided by Tiger Trade Technology Pte. Ltd.

TEMA ONCOLOGY ETF

41.65
-0.3620-0.86%
Post-market: 41.64-0.0125-0.03%16:10 EDT
Volume:18.51K
Turnover:772.61K
Market Cap:207.43M
PE:- -
High:42.15
Open:42.15
Low:41.43
Close:42.01
52wk High:47.00
52wk Low:26.62
Shares:4.98M
Float Shares:4.98M
Volume Ratio:0.54
T/O Rate:0.37%
Dividend:0.02
Dividend Rate:0.05%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

RBC Capital Sticks to Their Buy Rating for Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 15

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), ArriVent BioPharma, Inc. (AVBP)

TIPRANKS
·
Sep 15

Revolution Medicines Gets US FDA Breakthrough Therapy Designation for Rasonque To Treat Pancreatic Cancer

MT Newswires Live
·
Sep 15

Lilly Says Foundayo Has Captured over 30% of New US Patients on Oral Weight-Loss Drugs

Reuters
·
Sep 15

Revolution Medicines granted Breakthrough Therapy Designation to Rasonque by FDA

TIPRANKS
·
Sep 15

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for Rasonque™ (Daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

THOMSON REUTERS
·
Sep 15

Eli Lilly Stock (LLY) Has 45% Upside, Says Citigroup

TIPRANKS
·
Sep 15

Novo Nordisk is Dropping Some Weight. it Still Faces a Bigger Challenge.

Dow Jones
·
Sep 15

Eli Lilly Exec Says Co NOW Has More than 30% Share in New Starts Within Oral Obesity Treatment Market -Morgan Stanley Conf

THOMSON REUTERS
·
Sep 15

Eli Lilly and Co Stock (LLY) Moved Up by 3.01% on Sep 14: Drivers Behind the Movement

TradingKey
·
Sep 15

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Sep 14

Eli Lilly Announces R$ 0.2 Per Unit Dividend for 3Q 2026 BDRs

Reuters
·
Sep 14

Legend Biotech Updates and Expands Cell Therapy Clinical Pipeline

TIPRANKS
·
Sep 14

BioNTech's Lung Cancer Drug Nearly Doubles Survival in Late-Stage Trial, Boosting Oncology Pivot

Stock News
·
Sep 14

One State's Battle to Stop People from Taking Unapproved Weight-Loss Drugs

Dow Jones
·
Sep 14

Analysts Offer Insights on Healthcare Companies: Revolution Medicines (RVMD) and Cooper Co (COO)

TIPRANKS
·
Sep 14

Roche announces MediLink’s phase III trial of Tam-Peli met primary endpoint

TIPRANKS
·
Sep 13

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Dow Jones
·
Sep 12

Sector Update: Healthcare Stocks Ease in Afternoon Trading

MT Newswires Live
·
Sep 12